After a decade of laboratory tests on mice and human tissues, University of Edinburgh cardiologist Jack Andrews, Miller, and colleagues recruited 14 volunteers to directly inhale different concentrations of graphene oxide nanoparticles.

Their blood pressure, clotting, and inflammation markers were measured along with lung function before breathing in the particles and every two hours during the exposure. The process was repeated again two weeks later.